Sanjay Sehgal, Ph.D.

Chief Regulatory Affairs and Quality Assurance Officer

Dr. Sehgal’s core expertise includes regulatory strategy development, authoring and reviewing regulatory submissions, and negotiating approvals for New Drug Applications (NDAs). Sanjay has led and/or supported the regulatory strategy development for multiple Investigational New Drug Applications and NDAs, and has negotiated approvals for eleven (11) NDAs while working at GlaxoSmithKline, TAP Pharmaceuticals, Procter & Gamble Pharmaceuticals, Wyeth Research, Aprecia and Celularity.

Dr. Sehgal completed a Bachelor of Pharmacy degree in India and a Ph.D. in Pharmaceutics from the University of Alberta, Edmonton, Canada. Sanjay was the Chair of Regulatory Sciences Section of the American Association of Pharmaceutical Scientists organization during 2007-08 and has chaired several symposia and roundtable discussions at AAPS, DIA and other associations.